Abstract
The Sendai virus V protein is a nonstructural trans-frame protein whose cysteine-rich C-terminal half is fused to the acidic N-terminal half of the P protein via mRNA editing. We recently created a mutant by disrupting the editing motif, which is devoid of mRNA editing and hence unable to produce the V protein, and demonstrated that this V(-) virus replicated normally or even faster with augmented gene expression and cytopathogenicity in cells in vitro, but was strongly attenuated in pathogenicity for mice (A. Kato, K. Kiyotani, Y. Sakai, T. Yoshida, and Y. Nagai, EMBO J. 16:578-587, 1997). Thus, although categorized as a nonessential protein, the V protein appeared to encode a luxury function required for the viral in vivo pathogenesis. Here, we created another version of a V-deficient mutant, VdeltaC, encoding only the N-terminal half but not the V-specific C-terminal half, by introducing a stop codon in the trans-V frame, and then we compared its in vitro and in vivo phenotypes with those of the V(-) and wild-type viruses. The VdeltaC virus was found to be similar to the wild-type virus in vitro with no augmented gene expression and cytopathogenicity, but in vivo, it resembled the V(-) virus, displaying a similarly attenuated phenotype. Thus, the pathogenicity determinant in the V protein was mapped to the C-terminal half. The N-terminal half was likely sufficient to confer normal (wild-type) in vitro phenotypes.
Full Text
The Full Text of this article is available as a PDF (1.9 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson M. J. Innate cytotoxicity of CBA mouse spleen cells to Sendai virus-infected L cells. Infect Immun. 1978 Jun;20(3):608–612. doi: 10.1128/iai.20.3.608-612.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anderson M. J. The role of interferon in the NK cell killing of virus-infected target cells. J Hyg (Lond) 1982 Oct;89(2):347–351. doi: 10.1017/s0022172400070881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Curran J., Boeck R., Kolakofsky D. The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J. 1991 Oct;10(10):3079–3085. doi: 10.1002/j.1460-2075.1991.tb07860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Curran J., Kolakofsky D. Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J. 1988 Jan;7(1):245–251. doi: 10.1002/j.1460-2075.1988.tb02806.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Curran J., Marq J. B., Kolakofsky D. An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol. 1995 Feb;69(2):849–855. doi: 10.1128/jvi.69.2.849-855.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Curran J., Pelet T., Kolakofsky D. An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation. Virology. 1994 Aug 1;202(2):875–884. doi: 10.1006/viro.1994.1409. [DOI] [PubMed] [Google Scholar]
- Curran J. Reexamination of the Sendai virus P protein domains required for RNA synthesis: a possible supplemental role for the P protein. Virology. 1996 Jul 1;221(1):130–140. doi: 10.1006/viro.1996.0359. [DOI] [PubMed] [Google Scholar]
- Curran J., de Melo M., Moyer S., Kolakofsky D. Characterization of the Sendai virus V protein with an anti-peptide antiserum. Virology. 1991 Sep;184(1):108–116. doi: 10.1016/0042-6822(91)90827-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Delenda C., Hausmann S., Garcin D., Kolakofsky D. Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology. 1997 Feb 3;228(1):55–62. doi: 10.1006/viro.1996.8354. [DOI] [PubMed] [Google Scholar]
- Fagni L., Olivier M., Lafon-Cazal M., Bockaert J. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells. Mol Pharmacol. 1995 Jun;47(6):1239–1247. [PubMed] [Google Scholar]
- Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galinski M. S., Troy R. M., Banerjee A. K. RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology. 1992 Feb;186(2):543–550. doi: 10.1016/0042-6822(92)90020-P. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garcin D., Pelet T., Calain P., Roux L., Curran J., Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J. 1995 Dec 15;14(24):6087–6094. doi: 10.1002/j.1460-2075.1995.tb00299.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gooding L. R. Virus proteins that counteract host immune defenses. Cell. 1992 Oct 2;71(1):5–7. doi: 10.1016/0092-8674(92)90259-f. [DOI] [PubMed] [Google Scholar]
- Hamaguchi M., Yoshida T., Nishikawa K., Naruse H., Nagai Y. Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology. 1983 Jul 15;128(1):105–117. doi: 10.1016/0042-6822(83)90322-7. [DOI] [PubMed] [Google Scholar]
- Harty R. N., Palese P. Measles virus phosphoprotein (P) requires the NH2- and COOH-terminal domains for interactions with the nucleoprotein (N) but only the COOH terminus for interactions with itself. J Gen Virol. 1995 Nov;76(Pt 11):2863–2867. doi: 10.1099/0022-1317-76-11-2863. [DOI] [PubMed] [Google Scholar]
- Kato A., Fujino M., Nakamura T., Ishihama A., Otaki Y. Gene organization of chicken anemia virus. Virology. 1995 Jun 1;209(2):480–488. doi: 10.1006/viro.1995.1280. [DOI] [PubMed] [Google Scholar]
- Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 1997 Feb 3;16(3):578–587. doi: 10.1093/emboj/16.3.578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kato A., Sakai Y., Shioda T., Kondo T., Nakanishi M., Nagai Y. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells. 1996 Jun;1(6):569–579. doi: 10.1046/j.1365-2443.1996.d01-261.x. [DOI] [PubMed] [Google Scholar]
- Kiyotani K., Takao S., Sakaguchi T., Yoshida T. Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology. 1990 Jul;177(1):65–74. doi: 10.1016/0042-6822(90)90460-9. [DOI] [PubMed] [Google Scholar]
- Kröncke K. D., Fehsel K., Schmidt T., Zenke F. T., Dasting I., Wesener J. R., Bettermann H., Breunig K. D., Kolb-Bachofen V. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem Biophys Res Commun. 1994 Apr 29;200(2):1105–1110. doi: 10.1006/bbrc.1994.1564. [DOI] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Liston P., Briedis D. J. Measles virus V protein binds zinc. Virology. 1994 Jan;198(1):399–404. doi: 10.1006/viro.1994.1050. [DOI] [PubMed] [Google Scholar]
- Müller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 1994 Jun 24;264(5167):1918–1921. doi: 10.1126/science.8009221. [DOI] [PubMed] [Google Scholar]
- Nathan C. Natural resistance and nitric oxide. Cell. 1995 Sep 22;82(6):873–876. doi: 10.1016/0092-8674(95)90019-5. [DOI] [PubMed] [Google Scholar]
- Park K. H., Krystal M. In vivo model for pseudo-templated transcription in Sendai virus. J Virol. 1992 Dec;66(12):7033–7039. doi: 10.1128/jvi.66.12.7033-7039.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paterson R. G., Lamb R. A. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol. 1990 Sep;64(9):4137–4145. doi: 10.1128/jvi.64.9.4137-4145.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paterson R. G., Leser G. P., Shaughnessy M. A., Lamb R. A. The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology. 1995 Apr 1;208(1):121–131. doi: 10.1006/viro.1995.1135. [DOI] [PubMed] [Google Scholar]
- Pelet T., Curran J., Kolakofsky D. The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site. EMBO J. 1991 Feb;10(2):443–448. doi: 10.1002/j.1460-2075.1991.tb07966.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Radecke F., Billeter M. A. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology. 1996 Mar 1;217(1):418–421. doi: 10.1006/viro.1996.0134. [DOI] [PubMed] [Google Scholar]
- Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dötsch C., Christiansen G., Billeter M. A. Rescue of measles viruses from cloned DNA. EMBO J. 1995 Dec 1;14(23):5773–5784. doi: 10.1002/j.1460-2075.1995.tb00266.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rolph M. S., Cowden W. B., Medveczky C. J., Ramshaw I. A. A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J Virol. 1996 Nov;70(11):7678–7685. doi: 10.1128/jvi.70.11.7678-7685.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ryan K. W., Morgan E. M., Portner A. Two noncontiguous regions of Sendai virus P protein combine to form a single nucleocapsid binding domain. Virology. 1991 Jan;180(1):126–134. doi: 10.1016/0042-6822(91)90016-5. [DOI] [PubMed] [Google Scholar]
- Schneider H., Kaelin K., Billeter M. A. Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology. 1997 Jan 20;227(2):314–322. doi: 10.1006/viro.1996.8339. [DOI] [PubMed] [Google Scholar]
- Shioda T., Hidaka Y., Kanda T., Shibuta H., Nomoto A., Iwasaki K. Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res. 1983 Nov 11;11(21):7317–7330. doi: 10.1093/nar/11.21.7317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smallwood S., Ryan K. W., Moyer S. A. Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology. 1994 Jul;202(1):154–163. doi: 10.1006/viro.1994.1331. [DOI] [PubMed] [Google Scholar]
- Steward M., Samson A. C., Errington W., Emmerson P. T. The Newcastle disease virus V protein binds zinc. Arch Virol. 1995;140(7):1321–1328. doi: 10.1007/BF01322759. [DOI] [PubMed] [Google Scholar]
- Takao S. I., Kiyotani K., Sakaguchi T., Fujii Y., Seno M., Yoshida T. Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses. J Virol. 1997 Jan;71(1):832–838. doi: 10.1128/jvi.71.1.832-838.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas S. M., Lamb R. A., Paterson R. G. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell. 1988 Sep 9;54(6):891–902. doi: 10.1016/S0092-8674(88)91285-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vidal S., Curran J., Kolakofsky D. A stuttering model for paramyxovirus P mRNA editing. EMBO J. 1990 Jun;9(6):2017–2022. doi: 10.1002/j.1460-2075.1990.tb08330.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vidal S., Curran J., Kolakofsky D. Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol. 1990 Jan;64(1):239–246. doi: 10.1128/jvi.64.1.239-246.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wardrop E. A., Briedis D. J. Characterization of V protein in measles virus-infected cells. J Virol. 1991 Jul;65(7):3421–3428. doi: 10.1128/jvi.65.7.3421-3428.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]